Antibody-coupled Liposome Products

Introduction of Antibody-coupled Liposomes

Antibody-coupled liposomes (Immunoliposomes) are specialized nanoparticles that combine the benefits of liposomes with the specificity of antibodies. These innovative delivery systems offer targeted delivery of drugs and other therapeutic agents to specific cells or tissues while minimizing off-target effects. Creative Biolabs is excited to provide you with personalized conjugation solutions that fit your unique needs! Our team is here to help with expert antibody-liposome conjugated custom products, all designed to make your project a success.

Fig 1. Schematic representation of the different types of liposomal drug delivery systems. Distributed under Open Access license CC BY-SA 3.0, from Wiki, without modification.

Key Features

• Targeted Delivery: Antibody coupled liposomes are designed to selectively bind to specific cell surface receptors or antigens, allowing for targeted delivery of drugs to specific cells or tissues.
• Enhanced Efficacy: By delivering drugs directly to the target site, antibody-coupled liposomes can enhance the efficacy of therapeutic agents and reduce side effects associated with systemic administration.
• Improved Pharmacokinetics: Liposomes can protect drugs from degradation and clearance in the body, while antibodies can increase the circulation time and enhance the accumulation of liposomes at the target site.
• Versatile Applications: Antibody-coupled liposomes have a wide range of potential applications in the treatment of cancer, infectious diseases, autoimmune diseases, inflammatory disorders, and other conditions.

Applications of Immunoliposomes

• Cancer Therapy

Antibody-coupled liposomes can be used to selectively deliver chemotherapy drugs to cancer cells, while sparing healthy tissues. Immunoliposomes are a promising area of research in cancer therapy, as they can target cancer cells with high specificity by using antibodies that bind to overexpressed or mutated surface antigens. A notable instance of this approach is the targeting of the HER2 antigen in breast cancer by employing the antibody trastuzumab conjugated to liposomal carriers, facilitating the selective delivery of chemotherapy drugs to malignant cells. Ongoing clinical trials are also exploring the targeting of additional antigens, such as EGFR, in various cancers. The application of immunoliposomes holds promise for minimizing the toxicity and adverse effects commonly associated with conventional chemotherapy, while concurrently enhancing the efficacy of cancer treatment modalities.

We summarized a series of studies reporting targeted liposomes using antibodies for a variety of cancer receptors.

• Immunotherapy

Antibody coupled liposomes can deliver immunomodulators or antigens to immune cells, enhancing the body's immune response against pathogens or cancer cells.

• Targeted Drug Delivery

Antibody coupled liposomes can deliver a variety of therapeutic agents, including small molecules, proteins, nucleic acids, and imaging agents, to specific cells or tissues. Immunoliposomes are liposomal drug delivery systems that are modified with antibodies or antibody fragments to target specific antigens on diseased cells. This targeting allows for localized and controlled drug release, reducing systemic toxicity and increasing efficacy. By conjugating antibodies to the external end of PEG chains on the liposome, the binding capacity is improved. Antigen-specific immunoliposomes have been used to treat various inflammatory diseases by targeting specific cell surface antigens, such as ICAM-1 in rheumatoid arthritis. This targeted delivery system offers a promising approach for personalized medicine and precision therapy.

Liposome Types

There are various types of liposomes utilized in drug delivery and biomedical research, each offering unique advantages and applications. For instance, cationic liposomes are positively charged and can enhance absorption and uptake into cells with negatively charged membranes, improving the efficiency of drug delivery. Long-circulating liposomes have an extended lifespan in circulation, allowing drugs to remain in the body for longer periods. pH-sensitive liposomes undergo structural changes at specific pH levels, facilitating the targeted release of drugs in tissues or cells. Additionally, protein-lipid complexes formed by binding membrane proteins with liposomes are utilized to transport proteins and other large molecular drugs. These diverse types of liposomes play a crucial role in enhancing drug delivery and advancing biomedical research.

For inquiries or to place an order, please feel free to contact us.

Explore Our Complete Range of Antibody Coupled Liposomes:

Our customer service representatives are available 24 hours a day, from Monday to Sunday. Contact Us

Can't find the products you're looking for? Try to filter in the left sidebar.Filter By Tag

For Research Use Only. Not For Clinical Use.